Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...
Mark Cussen, CMFC, has 13+ years of experience as a writer and provides financial education to military service members and the public. Mark is an expert in investing, economics, and market news.
Every time Dylan publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
L’Agenzia Italiana del Farmaco ha ammesso alla rimborsabilità Capmatinib, un nuovo farmaco orale di precisione indicato per i pazienti con tumore al polmone non a piccole cellule (NSCLC) METex14 ...
Due importanti novità potenzialmente rivoluzionarie per la terapia del cancro al polmone. Una proviene da Cuba, dove è già utilizzata dal 2011. Si tratta di un vaccino terapeutico che agisce in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback